Navigation Links
Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Date:11/4/2009

es. The firm offers strategic advice and assistance to its clients regarding mergers and acquisitions.

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Star Scientific, Inc. and its consolidated subsidiaries (collectively, the "Company") has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates", "believes", "estimates", "expects", "plans", "intends" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in, or implied by, such statements. These risks, uncertainties and contingencies include, without limitation, the challenges inherent in new product development initiatives, the uncertainties inherent in the progress of scientific research, the Company's ability to raise additional capital in the future necessary to maintain its business, potential disputes concerning the Company's intellectual property, risks associated with litigation regarding such intellectual property, potential delays in obtaining any necessary government approvals of the Company's low-TSNA tobacco products, market acceptance of the Company's new smokeless tobacco products, competition from companies with greater resources than the Company, the Company's decision not to join the Master Settlement Agreement ("MSA"), the effect of state statutes adopted under the MSA, and the Company's dependence on key employees and on its strategic relationships with Brown & Williamson Tobacco Corporation in light of its combination with RJ Reynolds Tobacco Company, Inc. The impact of potential litigation, if initiated against or by individual states th
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cytochroma Appoints Dr. John Cunningham to its Scientific Advisory Board
2. DOE to Explore Scientific Cloud Computing at Argonne, Lawrence Berkeley National Laboratories
3. Dr. Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board
4. Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
5. Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research
6. Irvine Scientific and Selexis to Announce Results of Successful Collaboration
7. Nanogea Announces New Scientific Advisory Board Members
8. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
9. Global Public Health the Focus of Scientific Conference
10. QImaging Introduces "QTube," a Video-based Learning Tool for Scientific & Industrial Digital Imaging
11. Boston Scientific Announces Release of Next-Generation iLab(R) System Software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)..., CHAMPAIGN, Ill. Imagine a polka-dotted postage...y toxins simply by changing colors. , As reporte...mistry , Kenneth Suslick and his team at the Unive...e for the general detection of toxic industrial ch...e and works by visualizing odors. This sensor ar...
(Date:11/18/2009)..., , IRVINE, Calif., Nov. 18 /PRNewswire-Firs...of Pulse CO-Oximetry(TM) and Measure-Through Motio...y that Lyon, France-based Uni.H.A., one of the lar...O) in France, has signed a multi-year purchasing a...lse oximeters. The agreement offers preferred con...
(Date:11/18/2009)... Promega Corporation and S...racterizing DNA-protein interactions. , ...8, 2009 -- Promega Corporation and SwitchGear Geno...A-protein interactions. Results of a study using t...oter assays demonstrate the ability to correlate D...
(Date:11/18/2009)..., , BALTIMORE, Nov. 18 /PRNewswire-FirstC...tin Board: CSBR), an oncology drug development com...at accelerating the development and enhancing the ...ive licensing agreement with Yale University and S...Bithionol for cancer treatment. Scientists from Y...
Breaking Biology Technology:Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4
...ing belief that whenever a state company is acquir...ip inevitably harms the state,s economy. But the r... Networks Corp . by Illinois-based CDW Corp . has...ates, according to those closest to the deal. , ,T... in both companies and an attorney familiar with t...
...ear, the City of Madison received recognition as...le municipalities in the country. , ,In its 2006 ...t , a national research and advisory institute on ... and local government, honored the city as the top...ion category. Madison tied with the City of Alexa...
...last week at the Milwaukee School of Engineering ...messages. , ,Mary Glass of Campaign Neighborhood...the issue for Milwaukee neighborhoods, delivered a...e everyone the critical opportunity to take advant... the citizenry should be closer to the decision pr...
Other Biology Technology:Anatomy of a deal: CDW and Berbee 2Anatomy of a deal: CDW and Berbee 3Anatomy of a deal: CDW and Berbee 4Handicapping Milwaukee's wireless initiative 2Handicapping Milwaukee's wireless initiative 3Handicapping Milwaukee's wireless initiative 4Handicapping Milwaukee's wireless initiative 5
(Date:11/19/2009)...1 + 1 = more than 2: The offspring of two inbred s...s. Characterizing the gene-level variability that ...brid vigor, could boost our ability to custom-tail... content for human consumption or high glucose con...ly released DNA sequence of the common corn strain...
(Date:11/19/2009)...genetic diversity in maize, also known as corn, re... a gene map that should pave the way to significan...f food, fuel, animal feed and fiber around the wor...own as a haplotype map, charts genetic diversity a...nes of maize. The research team, led by U.S. Depar...
(Date:11/19/2009)...f researchers at Louisiana Tech University has fou...s a natural herbicide against giant salvinia. , ...eed that can block all sunlight penetration into b... ideal conditions, it,s been reported that giant s...r. H. Lynn Walker, professor of biological science...
Breaking Biology News(10 mins):U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Microorganism may provide key to combating giant salvinia throughout Louisiana 2NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 1Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 2Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 3Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 4Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 5Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 1Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 4
...OR, N.Y. (Mon., Feb. 2, 2009) -- By using OP9-DL... the differentiation of embryonic stem cells into ...h,s issue of Cold Spring Harbor Protocols ( www.... of methods from Juan Carlos Ziga-Pflcker,s labora...unology.utoronto.ca/faculty/directory/zunigapfluck...
...rtable at first, but doing exercises to strengthen... surgery due to osteoarthritis is critical to your...our new knee to nearly that of a healthy adult you...laware study published in the February issue of A...e Lynn Snyder-Mackler, Alumni Distinguished Profes...
...mon colds typically cause a week of sneezing, ache... nose and a few used sick days behind. But what if...an adenovirus type-3 is known as the "uncommon col...e throat, cough and feverare eerily similar to tho...virus. The difference is that, unlike the common c...
Other Biology News:Cold Spring Harbor Protocols features stem cell differentiation, plant RNAi methods 2Exercise after knee replacement critical 2New vaccine developed for preventing 'uncommon cold' virus 2
DHFR-1 FP-1 Forward Sequencing Primer from EPICENTRE Biotechnologies
... Synthetic peptide derived from the N-terminal reg... Specific for the N-terminus of the ~225 kDa ZO-1 ...e controls: MDCK-II A431 Caco-2 Rat-1 NRK-52E cell...mossy fiber terminal tissues Human pancreas prosta...
Goat Anti-Human Carnosine Dipeptidase 1 Polyclonal Antibody, Unconjugated from R&D Systems
BRIJ 35 - 1 Gallon from GeneTex
Biology Products: